bioAffinity Technologies, Inc. (BIAF)
USD 0.51
(2.9%)
USD 0.51
(2.9%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.22 Million USD | -32.51% |
| 2022 | 12.18 Million USD | 738.23% |
| 2021 | 1.45 Million USD | 898.12% |
| 2020 | 145.6 Thousand USD | -77.9% |
| 2019 | 658.81 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 6.65 Million USD | -17.3% |
| 2024 Q1 | 8.04 Million USD | -2.1% |
| 2023 Q4 | 8.22 Million USD | -19.31% |
| 2023 FY | 8.22 Million USD | -32.51% |
| 2023 Q2 | 8.87 Million USD | -15.2% |
| 2023 Q1 | 10.46 Million USD | -14.1% |
| 2023 Q3 | 10.18 Million USD | 14.83% |
| 2022 Q2 | 940.74 Thousand USD | -30.47% |
| 2022 Q1 | 1.35 Million USD | -6.9% |
| 2022 FY | 12.18 Million USD | 738.23% |
| 2022 Q4 | 12.18 Million USD | -13.37% |
| 2022 Q3 | 14.06 Million USD | 1394.84% |
| 2021 Q4 | 1.45 Million USD | 310.47% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q3 | 354.06 Thousand USD | 0.0% |
| 2021 FY | 1.45 Million USD | 898.12% |
| 2020 FY | 145.6 Thousand USD | -77.9% |
| 2020 Q4 | 145.6 Thousand USD | 0.0% |
| 2019 FY | 658.81 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biodesix, Inc. | 99.09 Million USD | 91.703% |
| Castle Biosciences, Inc. | 477.81 Million USD | 98.279% |
| Exact Sciences Corporation | 6.47 Billion USD | 99.873% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 99.748% |
| 23andMe Holding Co. | 395.16 Million USD | 97.919% |
| NeoGenomics, Inc. | 1.68 Billion USD | 99.511% |
| Neogen Corporation | 4.58 Billion USD | 99.821% |
| Inotiv, Inc. | 856.53 Million USD | 99.04% |
| Psychemedics Corporation | 13.27 Million USD | 38.044% |
| RadNet, Inc. | 2.88 Billion USD | 99.715% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 90.547% |
| Illumina, Inc. | 10.11 Billion USD | 99.919% |
| Aspira Women's Health Inc. | 6.26 Million USD | -31.293% |
| Prenetics Global Limited | 254.17 Million USD | 96.765% |
| iSpecimen Inc. | 15.81 Million USD | 48.028% |
| OpGen, Inc. | 1.88 Million USD | -336.788% |
| T2 Biosystems, Inc. | 34.79 Million USD | 76.373% |
| Standard BioTools Inc. | 323.06 Million USD | 97.455% |
| Neuronetics, Inc. | 115.83 Million USD | 92.902% |
| Precipio, Inc. | 18.1 Million USD | 54.58% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | 40.332% |
| Exagen Inc. | 56.94 Million USD | 85.562% |
| Bionano Genomics, Inc. | 214.4 Million USD | 96.165% |
| CareDx, Inc | 484.61 Million USD | 98.303% |
| Check-Cap Ltd. | 25.01 Million USD | 67.136% |
| Twist Bioscience Corporation | 776.4 Million USD | 98.941% |
| Guardant Health, Inc. | 1.78 Billion USD | 99.54% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | 27.88% |
| Natera, Inc. | 1.45 Billion USD | 99.436% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 99.354% |
| Sera Prognostics, Inc. | 95.44 Million USD | 91.386% |
| OPKO Health, Inc. | 2.01 Billion USD | 99.591% |
| Personalis, Inc. | 225.09 Million USD | 96.348% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | 95.835% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | 39.776% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 99.314% |
| ICON Public Limited Company | 16.98 Billion USD | 99.952% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 90.547% |
| MDxHealth SA | 129.13 Million USD | 93.633% |
| Prenetics Global Limited | 254.17 Million USD | 96.765% |
| DarioHealth Corp. | 96.38 Million USD | 91.47% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -21.726% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 99.504% |
| Mainz Biomed B.V. | 15.4 Million USD | 46.645% |
| Trinity Biotech plc | 59.43 Million USD | 86.167% |
| Sotera Health Company | 3.13 Billion USD | 99.737% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | 0.0% |